Clinical trialNCT03634332UnknownPhase 2Interventional

Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC

SponsorPancreatic Cancer Research TeamEnrollment35Pancreatic CancerPancreatic Ductal AdenocarcinomaPancreatic Neoplasms

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Gabriella Chiorean, MD
Seattle Cancer Care Alliance--University of Washington
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Banner Health - Md Anderson Cancer Center
Gilbert, Arizona, United States
Tomislav Dragovich, MD, PhD
Not, yet, recruiting
Cedars Sinai Medical Center
Los Angeles, California, United States
Andrew Hendifar, MD
Not, yet, recruiting
Rutgers - Cancer Institute of New Jersey (cinj)
New Brunswick, New Jersey, United States
Active, not recruiting
University of Washington--Seattle Cancer Care Alliance
Seattle, Washington, United States
David B Zhen, MDElena G Chiorean, MD
Recruiting
Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Paul Ritch, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 May 2019
Primary completion: 31 Oct 2020
Completion: 31 Jan 2021
Last update posted: 7 May 2019
Registered enrollment: 35
Registry id: NCT03634332

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.